Myelitis, Transverse clinical trials

The registry lists 32 studies for Myelitis, Transverse across more than 10 countries. 10 are recruiting or about to start. 7 of them are mainly about Myelitis, Transverse (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27. Counting its narrower condition Neuromyelitis Optica too: 195 studies, 87 open.

Get an email when these change. Save the Myelitis, Transverse studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 14
Recruiting: 6
Terminated: 3
Active, not recruiting: 3
Not yet recruiting: 2
Status unknown: 2

Phase

Phase 3: 8
Phase 2: 5
Phase 1: 4
Phase 4: 2

Where

United States: 23
United Kingdom: 7
Canada: 5
Denmark: 4
Italy: 4
Spain: 4

Who runs them

University of Texas Southwestern Medical Center (4) · Alexion Pharmaceuticals, Inc. (4) · Johns Hopkins University (2) · University of Alabama at Birmingham (2) · Q Therapeutics, Inc. (1) · State University of New York at Buffalo (1) · Beth Israel Deaconess Medical Center (1) · Assiut University (1)

What is being tested here

Drugs under test in Myelitis, Transverse studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Vibegron	1	1	1
Eculizumab	0	3	3
Ravulizumab	0	1	1
Mitoxantrone	0	0	1
Ublituximab	0	0	1
ABX-1431	0	0	1
4-Aminopyridine	0	0	1
Interferon beta-1a	0	0	1
Rituximab	0	0	1
Immunoglobulins, Intravenous	0	1	1

Coming up

2phase 3 studies under way

3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Dec 2026The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury · University of Alabama at Birmingham
Jul 2027Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis · Q Therapeutics, Inc.
Sep 2027Pattern of AFP in Chhidren Admitted at Sohag University Hospital · Mohamed Aboelhamd Ali

Who these studies take

Of the 6 Myelitis, Transverse studies recruiting now, 3 (50%) set no upper age limit and 3 (50%) stop at 75 or younger. 3 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	3 (50%)	3 (50%)
18	5 (83%)	5 (83%)
30	5 (83%)	5 (83%)
40	4 (67%)	4 (67%)
50	4 (67%)	4 (67%)
65	4 (67%)	4 (67%)
75	3 (50%)	3 (50%)
85	3 (50%)	3 (50%)

Across all 32 studies, recruiting or not: 44% stop at 75 or younger and 28% at 65; 44% take children; 0% are for women only and 0% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 32 of 32. search them.